Effects of CPT-11 in combination with ot
โ
Yasuhiko Kano; Kenichi Suzuki; Miyuki Akutsu; Keiichi Suda; Yoshiharu Indue; Min
๐
Article
๐
1992
๐
John Wiley and Sons
๐
French
โ 746 KB
CPT-I I , 7-ethyl-I0-[4-( I -piperidino)-I -piperidino]carbonyloxy camptothecin, is a newly developed water-soluble camptothecin derivative now undergoing phase4 evaluation. In an attempt to establish whether the combination of CPT-I I with other standard anti-cancer agents would be of any benefit,